Fibroblast growth factor 21 alleviates diabetes-induced cognitive decline

Xi Zhang,Hong Zheng,Zhitao Ni,Yuyin Shen,Die Wang,Wenqing Li,Liangcai Zhao,Chen Li,Hongchang Gao

DOI: https://doi.org/10.1093/cercor/bhad502

IF: 4.861

2024-01-15

Cerebral Cortex

Abstract:Diabetes mellitus (DM) causes damage to the central nervous system, resulting in cognitive impairment. Fibroblast growth factor 21 (FGF21) exhibits the potential to alleviate neurodegeneration. However, the therapeutic effect of intracerebroventricular (i.c.v) FGF21 infusion on diabetes-induced cognitive decline (DICD) and its potential mechanisms remain unclear. In this study, the impact of FGF21 on DICD was explore d , and 1 H nuclear magnetic resonance (NMR)-based metabolomics plus 13 C NMR spectroscopy in combine with intravenous [1- 13 C]-glucose infusion were used to investigate the underlying metabolic mechanism. Results revealed that i.c.v FGF21 infusion effectively improved learning and memory performance of DICD mice; neuron loss and apoptosis in hippocampus and cortex were significantly blocked, suggesting a potential neuroprotective role of FGF21 in DICD. Metabolomics results revealed that FGF21 modulated DICD metabolic alterations related to glucose and neurotransmitter metabolism, which are characterized by distinct recovered enrichment of [3- 13 C]-lactate, [3- 13 C]-aspartate, [4- 13 C]-glutamine, [3- 13 C]-glutamine, [4- 13 C]-glutamate, and [4- 13 C]- γ-aminobutyric acid (GABA) from [1- 13 C]-glucose. Moreover, diabetes-induced neuron injury and metabolic dysfunctions might be mediated by PI3K/AKT/GSK-3β signaling pathway inactivation in the hippocampus and cortex, which were activated by i.c.v injection of FGF21. These findings indicate that i.c.v FGF21 infusion exerts its neuroprotective effect on DICD by remodeling cerebral glucose and neurotransmitter metabolism by activating the PI3K/AKT/GSK-3β signaling pathway.

neurosciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is Diabetes - Induced Cognitive Decline (DICD). Specifically, the research aims to explore the effect of Fibroblast Growth Factor 21 (FGF21) on cognitive decline in diabetic mice and its underlying mechanisms. Through experiments, researchers hope to verify whether FGF21 can improve cognitive impairment caused by diabetes by remodeling glucose and neurotransmitter metabolism in the brain and activating the PI3K/AKT/GSK - 3β signaling pathway. ### Research Background Diabetes Mellitus (DM) is a common metabolic syndrome, and high blood - glucose levels are its main feature. Diabetes not only affects multiple systems in the body but also damages the Central Nervous System (CNS), leading to cognitive decline. This cognitive decline involves impairment of memory, language, and judgment abilities. Although some pathological factors have been proposed, such as oxidative stress, inflammation, autophagy dysregulation, and neuronal apoptosis, effective treatment methods are currently lacking. Therefore, understanding the metabolic mechanisms of diabetes - induced cognitive decline is crucial for the discovery of new treatment methods. ### Research Objectives 1. **Evaluate the effect of FGF21 on the cognitive function of diabetic mice**: Use the Morris Water Maze Test to evaluate the improvement effect of FGF21 on the learning and memory abilities of diabetic mice. 2. **Explore the mechanism of action of FGF21**: Use 1H nuclear magnetic resonance (NMR) metabolomics and 13C NMR spectroscopy combined with intravenous injection of [1 - 13C]-glucose to study how FGF21 remodels glucose and neurotransmitter metabolism in the brain. 3. **Analyze the changes in the PI3K/AKT/GSK - 3β signaling pathway**: Use methods such as Western Blot to explore whether FGF21 exerts its neuroprotective effect by activating this signaling pathway. ### Main Findings - **FGF21 improves the cognitive function of diabetic mice**: The results of the water maze test show that FGF21 significantly shortens the escape latency of diabetic mice and increases the number of crossings, the residence time, and the swimming distance in the target quadrant. - **FGF21 reduces neuronal loss and apoptosis**: Nissl staining shows that FGF21 significantly increases the number of neurons in the hippocampus and cortex and reduces neuronal apoptosis. - **FGF21 remodels brain metabolism**: 1H NMR and 13C NMR analyses indicate that FGF21 reduces the elevated lactate and glucose contents in the brains of diabetic mice, while increasing the levels of neurotransmitters (such as GABA, glutamate, and aspartate) and the neuronal survival marker NAA. - **FGF21 activates the PI3K/AKT/GSK - 3β signaling pathway**: Western Blot results show that FGF21 significantly enhances the phosphorylation levels of PI3K, AKT, and GSK - 3β, thereby activating this signaling pathway. ### Conclusion This study confirms that FGF21 effectively improves diabetes - induced cognitive decline by remodeling glucose and neurotransmitter metabolism in the brain and activating the PI3K/AKT/GSK - 3β signaling pathway. These findings provide important scientific basis for the development of new treatment strategies.

Fibroblast growth factor 21 alleviates diabetes-induced cognitive decline

Exogenous fibroblast growth factor 1 ameliorates diabetes-induced cognitive decline via coordinately regulating PI3K/AKT signaling and PERK signaling

Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer's disease

FGF21 Protects against Aggravated Blood-Brain Barrier Disruption after Ischemic Focal Stroke in Diabetic db/db Male Mice via Cerebrovascular PPARγ Activation

Fibroblast growth factor 21 enhances learning and memory performance in mice by regulating hippocampal L-lactate homeostasis

Fibroblast Growth Factor-21 Alleviates Proteasome Injury Via Activation of Autophagy Flux in Parkinson's Disease.

Fibroblast growth factor 21 improves insulin sensitivity by modulating the bile acid-gut microbiota axis in type Ⅱ diabetic mice

GDF11 improves hippocampal neurogenesis and cognitive abilities in diabetic mice by reducing neural inflammation

The integrated analysis and underlying mechanisms of FNDC5 on diabetic induced cognitive deficits

Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart

FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction

Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs

Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

Fibroblast growth factor 21 protects the liver from apoptosis in a type 1 diabetes mouse model via regulating L-lactate homeostasis

FGF21 restores hippocampual mitochondrial dysfunction via enhancing Nrf2/HO-1 and AMPK/SirT1/PGC-1α signaling pathways to alleviate chronic unpredictable mild stress induced depressive like behaviors in mice

Methionine restriction alleviates diabetes-associated cognitive impairment via activation of FGF21

Depletion of gut microbiota facilitates fibroblast growth factor 21-mediated protection against acute pancreatitis in diabetic mice

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice

Fibroblast growth factor 21 improves diabetic cardiomyopathy by inhibiting ferroptosis via ferritin pathway